Association of intravenous digoxin use in acute heart failure with rapid atrial fibrillation and short-term mortality according to patient age, renal function, and serum potassium.
Òscar MiróEnrique Martín MojarroPedro Lopez-AyalaPere LlorensVíctor GilAitor Alquézar-ArbéCarlos BibianoJosé PavónMarta MassóIvo StrebelBegoña EspinosaSilvia Mínguez MasóJavier JacobJavier MillánJuan Antonio AnduezaHéctor AlonsoPablo Herrero-PuenteChristian Muellernull nullPublished in: European journal of emergency medicine : official journal of the European Society for Emergency Medicine (2024)
The use of intravenous digoxin in the ED was not associated with significant changes in 30-day mortality, which was confirmed irrespective of patient age or the existence of renal dysfunction or serum potassium disturbances.
Keyphrases
- acute heart failure
- atrial fibrillation
- case report
- cardiovascular events
- heart failure
- high dose
- emergency department
- risk factors
- oxidative stress
- type diabetes
- coronary artery disease
- cardiovascular disease
- catheter ablation
- direct oral anticoagulants
- venous thromboembolism
- low dose
- left atrial appendage
- oral anticoagulants
- mitral valve
- quantum dots